Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript
Open Access
- 3 July 2006
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 38 (4) , 319-320
- https://doi.org/10.1038/sj.bmt.1705437
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Modern Diagnosis and Treatment of Primary EosinophiliaActa Haematologica, 2005
- Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogeneticsLeukemia, 2005
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaBlood, 2004
- The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementBlood, 2004
- Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndromeBlood, 2004
- Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndromeBone Marrow Transplantation, 2002
- Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantationAmerican Journal of Hematology, 1988